Legal Opinion

In re Wellbutrin XL

District Court, E.D. Pennsylvania

Decided July 21, 2010No. Civil Action Nos. 08-2431, 08-2433PublishedCited by 13 opinions

1Opinion of the Court

MEMORANDUM

McLAUGHLIN, District Judge.

The plaintiffs in these two class actions bring suits against the producers of Wellbutrin XL, Biovail Corp., Biovail Laboratories, Biovail Laboratories International (together, “Biovail”), and its distributors, SmithKline Beecham Corp. and GlaxoSmithKline PLC (together, “GSK”), for illegally conspiring to prevent generic versions of Wellbutrin XL, or buproprion hydrochloride, from entering the American market.

The Court is presented with motions affecting class representation in both actions. In the direct purchaser action, the current class representative…

2Cases cited9 opinions

  1. Liberty Mutual Insurance Company v. Treesdale, Inc.Court of Appeals for the Third Circuit · 2005
  2. Brody v. SpangCourt of Appeals for the Third Circuit · 1992
  3. Sinclair v. Soniform, Inc.Court of Appeals for the Third Circuit · 1991
  4. John Ferguson, Jr. v. George H. Eakle John Ferguson, Jr. Lois KittredgeCourt of Appeals for the Third Circuit · 1974
  5. In Re Community Bank of Northern VirginiaCourt of Appeals for the Third Circuit · 2005

4 more not listed; retrieve them via the Exa API.

3Cited by13 opinions

  1. In re Wellbutrin XL Antitrust LitigationDistrict Court, E.D. Pennsylvania · 2011
  2. Payne v. Tri-State Careflight, LLCDistrict Court, D. New Mexico · 2017
  3. Tagupa v. VIPDESK.Hawaii Supreme Court · 2015
  4. McDonald v. Wells Fargo Bank, N.A.District Court, W.D. Pennsylvania · 2019
  5. Quicken Loans, Inc. v. Winnecour (In re Dworek)United States Bankruptcy Court, W.D. Pennsylvania · 2018

8 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API